ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

By L’’Huillier Arnaud G   Ing Lorenzini Kuntheavy   Crisinel Pierre-Alex   Rebsamen Michela C   Fluss Joel   Korff Christian M   Barbe Remy P   Siegrist Claire-Anne   Dayer Pierre   Posfay-Barbe Klara M   Desmeules Jules A  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1493-1501

Future Medicine

Access to resources Recommend Favorite

Oseltamivir, zanamivir leading the charge against influenza H5N1

By  

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Fever Following Immunization with Influenza A (H1N1) Vaccine in Children: A Survey-Based Study in the Netherlands

By Broos Nancy   van Puijenbroek Eugène P.   >  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1109-1115

Adis International

Access to resources Recommend Favorite

Fight Against H1N1 Influenza A Virus: Recent Insights Towards the Development of Druggable Compounds

By  

Current Medicinal Chemistry, Vol. 23, Iss. 18, 2016-06 ,pp. : 1802-1817

Bentham Science Publishers

Access to resources Recommend Favorite

HAd-H5HA vaccine protects against H5N1 influenza in mice

By  

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite